#drugdevelopment search results

In 2025, C-Path proudly celebrates 20 years of impact. Take a look back at the highlights and the incredible individuals who made it all possible. Here's to the next chapter of innovation! f.mtr.cool/lglzgvzfjq #CPath20Years #DrugDevelopment #Collaboration


Every stage of drug development benefits from the right expertise. Explore how choosing between a CDMO, CMO, or CRO can define your project’s progress in our new blog. Read the full article here: hubs.la/Q03Q9lx-0 #NeulandLabs #CDMO #DrugDevelopment #Outsourcing

NeulandLabs's tweet image. Every stage of drug development benefits from the right expertise. Explore how choosing between a CDMO, CMO, or CRO can define your project’s progress in our new blog.
Read the full article here: hubs.la/Q03Q9lx-0 

#NeulandLabs #CDMO #DrugDevelopment #Outsourcing

❗️Prediction for #DrugDevelopment: Companies that wait to work on #LongCovid will regret it. This is a large & growing population (w/ very organized/engaged patient #advocacy, major unmet need, & no approved agents) whose disability has huge societal economic impact. Don’t wait.


Totally agree @curijoey - taking a post-#ESMO25 recovery pause in your beautiful home country 🇮🇹 🍷🫒⛪️ at the moment… before return to #drugdevelopment rat race! 🇦🇺

JiaJennyLiu's tweet image. Totally agree @curijoey - taking a post-#ESMO25 recovery pause in your beautiful home country 🇮🇹 🍷🫒⛪️ at the moment… before return to #drugdevelopment rat race! 🇦🇺
JiaJennyLiu's tweet image. Totally agree @curijoey - taking a post-#ESMO25 recovery pause in your beautiful home country 🇮🇹 🍷🫒⛪️ at the moment… before return to #drugdevelopment rat race! 🇦🇺

Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿

curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿


#ESMO2025 Berlin is SOON here 🇩🇪 🚀 My #Top10 for #drugdevelopment @myESMO Interesting new drugs coming out 🙌🏽 🧫 CAR-T 💉 ADC 🦠 Vaccines 🧪 New#ICIs 🎯 #therapies @ASCO @_SEOM @VHIO @MDAndersonNews @OncBrothers 🌍 Follow: #OncoAlertAF @OncoAlert What do you think? 💭👇🏽

DrMirallas's tweet image. #ESMO2025 Berlin is SOON here 🇩🇪

🚀 My #Top10 for #drugdevelopment @myESMO

Interesting new drugs coming out 🙌🏽
🧫 CAR-T
💉 ADC
🦠 Vaccines
🧪 New#ICIs
🎯 #therapies

@ASCO @_SEOM @VHIO @MDAndersonNews @OncBrothers

🌍 Follow:
#OncoAlertAF @OncoAlert

What do you think? 💭👇🏽

Is CRBP stock just practicing its yoga poses with all these ups and downs? Source: finquota.com/CRBP/ #StockMarket #DrugDevelopment #ClinicalTrials #NYSE #stock #stocks

FinQuota's tweet image. Is CRBP stock just practicing its yoga poses with all these ups and downs?

Source: finquota.com/CRBP/

#StockMarket #DrugDevelopment #ClinicalTrials #NYSE #stock #stocks

For over 10 years, we have made #DrugDiscovery & development steps faster & more predictable. Using what we’ve learned, we create educational resources to share this information with the #TranslationalScience community. To improve understanding of the complex #DrugDevelopment &…

ncats_nih_gov's tweet image. For over 10 years, we have made #DrugDiscovery & development steps faster & more predictable. Using what we’ve learned, we create educational resources to share this information with the #TranslationalScience community.

To improve understanding of the complex #DrugDevelopment &…
ncats_nih_gov's tweet image. For over 10 years, we have made #DrugDiscovery & development steps faster & more predictable. Using what we’ve learned, we create educational resources to share this information with the #TranslationalScience community.

To improve understanding of the complex #DrugDevelopment &…

BioNxt has launched a 15-day dosing optimisation study for its sublingual multiple sclerosis (MS) drug, marking the final step before human bioequivalence testing planned for early 2026. 🔗 Full story: buff.ly/gPjwCF7 #MultipleSclerosis #NeuroResearch #DrugDevelopment

editorNRTimes's tweet image. BioNxt has launched a 15-day dosing optimisation study for its sublingual multiple sclerosis (MS) drug, marking the final step before human bioequivalence testing planned for early 2026. 

🔗 Full story: buff.ly/gPjwCF7 

#MultipleSclerosis #NeuroResearch #DrugDevelopment…

#BioFuture2025 Day 3 spotlighted innovation at every level, from The New Policy Landscape to #AI in #DrugDevelopment. Thank you to our speakers, sponsors, and attendees for an incredible close to this year’s conference. See you in 2026! 💫

demy_sara's tweet image. #BioFuture2025 Day 3 spotlighted innovation at every level, from The New Policy Landscape to #AI in #DrugDevelopment. Thank you to our speakers, sponsors, and attendees for an incredible close to this year’s conference. See you in 2026! 💫
demy_sara's tweet image. #BioFuture2025 Day 3 spotlighted innovation at every level, from The New Policy Landscape to #AI in #DrugDevelopment. Thank you to our speakers, sponsors, and attendees for an incredible close to this year’s conference. See you in 2026! 💫
demy_sara's tweet image. #BioFuture2025 Day 3 spotlighted innovation at every level, from The New Policy Landscape to #AI in #DrugDevelopment. Thank you to our speakers, sponsors, and attendees for an incredible close to this year’s conference. See you in 2026! 💫

Pharmacology Jargon Simplified: Steady-State Occurs when drug input = drug elimination, giving consistent therapeutic levels. Key for chronic conditions, predictable effects & dosing optimization. Learn more 👉 ow.ly/KP4550WZEOq #Pharmacology #DrugDevelopment

Certara's tweet image. Pharmacology Jargon Simplified: Steady-State

Occurs when drug input = drug elimination, giving consistent therapeutic levels. Key for chronic conditions, predictable effects & dosing optimization.

Learn more 👉 ow.ly/KP4550WZEOq

#Pharmacology #DrugDevelopment

#ESMO25 #drugdevelopment 👉🏽 Botensilimab (CTLA4) + Balstilimab (PD1) 🗣️ Dr. Gordon 👥 Pantumor cold tumors and PD1 r/r ✅ ORR 17% ✅ 411 patients ✅ Durable responses in 🥶tumors ☣️ 10% =>G3 colitis @OncoAlert @myESMO @_SEOM @ASCO

DrMirallas's tweet image. #ESMO25
 #drugdevelopment 

👉🏽 Botensilimab (CTLA4) + Balstilimab (PD1)
🗣️ Dr. Gordon
👥 Pantumor cold tumors and PD1 r/r

✅ ORR 17%
✅ 411 patients
✅ Durable responses in 🥶tumors
☣️ 10% =>G3 colitis

@OncoAlert @myESMO @_SEOM @ASCO
DrMirallas's tweet image. #ESMO25
 #drugdevelopment 

👉🏽 Botensilimab (CTLA4) + Balstilimab (PD1)
🗣️ Dr. Gordon
👥 Pantumor cold tumors and PD1 r/r

✅ ORR 17%
✅ 411 patients
✅ Durable responses in 🥶tumors
☣️ 10% =>G3 colitis

@OncoAlert @myESMO @_SEOM @ASCO
DrMirallas's tweet image. #ESMO25
 #drugdevelopment 

👉🏽 Botensilimab (CTLA4) + Balstilimab (PD1)
🗣️ Dr. Gordon
👥 Pantumor cold tumors and PD1 r/r

✅ ORR 17%
✅ 411 patients
✅ Durable responses in 🥶tumors
☣️ 10% =>G3 colitis

@OncoAlert @myESMO @_SEOM @ASCO
DrMirallas's tweet image. #ESMO25
 #drugdevelopment 

👉🏽 Botensilimab (CTLA4) + Balstilimab (PD1)
🗣️ Dr. Gordon
👥 Pantumor cold tumors and PD1 r/r

✅ ORR 17%
✅ 411 patients
✅ Durable responses in 🥶tumors
☣️ 10% =>G3 colitis

@OncoAlert @myESMO @_SEOM @ASCO

#ESMO25 🚨 FIRST of my #Top10 #drugdevelopment 👉🏽 EVX-01 (vaccine) + Pembro 🗣️ @AdnanKhattakOnc 👥 Melanoma r/R PD-1/PD-L1 ✔️ ORR 75% w/92% sustained response at 24m❗ ✅ 81% vaccine neoantigens ✅ 100% vaccine induced T cells ☣️ ❌ Missing #tox @OncoAlert @myESMO @_SEOM @ASCO

DrMirallas's tweet image. #ESMO25
🚨 FIRST of my #Top10 #drugdevelopment 

👉🏽 EVX-01 (vaccine) + Pembro
🗣️ @AdnanKhattakOnc
👥 Melanoma r/R PD-1/PD-L1
✔️ ORR 75% w/92% sustained response at 24m❗
✅ 81% vaccine neoantigens
✅ 100% vaccine induced T cells
☣️ ❌ Missing #tox
@OncoAlert @myESMO @_SEOM @ASCO
DrMirallas's tweet image. #ESMO25
🚨 FIRST of my #Top10 #drugdevelopment 

👉🏽 EVX-01 (vaccine) + Pembro
🗣️ @AdnanKhattakOnc
👥 Melanoma r/R PD-1/PD-L1
✔️ ORR 75% w/92% sustained response at 24m❗
✅ 81% vaccine neoantigens
✅ 100% vaccine induced T cells
☣️ ❌ Missing #tox
@OncoAlert @myESMO @_SEOM @ASCO
DrMirallas's tweet image. #ESMO25
🚨 FIRST of my #Top10 #drugdevelopment 

👉🏽 EVX-01 (vaccine) + Pembro
🗣️ @AdnanKhattakOnc
👥 Melanoma r/R PD-1/PD-L1
✔️ ORR 75% w/92% sustained response at 24m❗
✅ 81% vaccine neoantigens
✅ 100% vaccine induced T cells
☣️ ❌ Missing #tox
@OncoAlert @myESMO @_SEOM @ASCO
DrMirallas's tweet image. #ESMO25
🚨 FIRST of my #Top10 #drugdevelopment 

👉🏽 EVX-01 (vaccine) + Pembro
🗣️ @AdnanKhattakOnc
👥 Melanoma r/R PD-1/PD-L1
✔️ ORR 75% w/92% sustained response at 24m❗
✅ 81% vaccine neoantigens
✅ 100% vaccine induced T cells
☣️ ❌ Missing #tox
@OncoAlert @myESMO @_SEOM @ASCO

With 200+ years of combined expertise, Certara’s Simcyp team leads the way in PBPK science—driving 125+ FDA approvals, EMA qualification, and global regulatory trust. See how Simcyp accelerates safer, smarter drug development: ow.ly/yVsu50X85I6 #PBPK #DrugDevelopment

Certara's tweet image. With 200+ years of combined expertise, Certara’s Simcyp team leads the way in PBPK science—driving 125+ FDA approvals, EMA qualification, and global regulatory trust. 

See how Simcyp accelerates safer, smarter drug development: ow.ly/yVsu50X85I6

 #PBPK #DrugDevelopment

Unlock the potential of HPAPIs in oncology. With safety-first manufacturing, peptide API expertise & seamless scale-up, Piramal Pharma Solutions advances your oncology pipeline with confidence. Read our blog: piramalpharmasolutions.com/resources/blog… #HPAPI #Oncology #DrugDevelopment #CDMO

PiramalPharma's tweet image. Unlock the potential of HPAPIs in oncology. With safety-first manufacturing, peptide API expertise & seamless scale-up, Piramal Pharma Solutions advances your oncology pipeline with confidence. Read our blog: piramalpharmasolutions.com/resources/blog… #HPAPI #Oncology #DrugDevelopment #CDMO

Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma

omalirp's tweet image. Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma
omalirp's tweet image. Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma

Can human mini-Hearts advance cardiovascular drug development? ddw-online.com/how-human-mini… Follow DDW; Business insights for the global scientific community #DrugDevelopment

DDWJournal's tweet image. Can human mini-Hearts advance cardiovascular drug development?

ddw-online.com/how-human-mini…

Follow DDW; Business insights for the global scientific community
#DrugDevelopment

We’re heading to #AAPS2025! Swing by booth 2917 and see how we’re advancing drug development with cutting-edge formulation technologies and predictive modeling. Schedule a meeting with us: ow.ly/4EGI50XatMn #DrugDevelopment


#Oncology #drugdevelopment is a wonderful journey. This cannot be done without #likeminded and #collaborative colleagues from around the World. There are only a few compounds that I've been involved in from the very beginning - #sevabertinib, together with #selpercatinib are 2…

herbloong's tweet image. #Oncology #drugdevelopment is a wonderful journey. This cannot be done without #likeminded and #collaborative colleagues from around the World.

There are only a few compounds that I've been involved in from the very beginning - #sevabertinib, together with #selpercatinib are 2…

‼️ Interested in use of registries for #oncology #DrugDevelopment & #regulatory decision-making? Or in pediatric #braintumor DMG/#DIPG? This is for you! Day 2 of free virtual public workshop: Th 8/28 10a-1p EDT. #ayacsm #btsm #raretumors #MedTwitter Link to register ⬇️ in 🧵

tmprowell's tweet image. ‼️ Interested in use of registries for #oncology #DrugDevelopment & #regulatory decision-making? Or in pediatric #braintumor DMG/#DIPG? This is for you! 

Day 2 of free virtual public workshop: Th 8/28 10a-1p EDT.

#ayacsm #btsm #raretumors
#MedTwitter 

Link to register ⬇️ in 🧵

In 2025, C-Path proudly celebrates 20 years of impact. Take a look back at the highlights and the incredible individuals who made it all possible. Here's to the next chapter of innovation! f.mtr.cool/lglzgvzfjq #CPath20Years #DrugDevelopment #Collaboration


Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: f.mtr.cool/edcqhezbhi

CPathInstitute's tweet image. Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: f.mtr.cool/edcqhezbhi

From target identification to clinical trials — every breakthrough medicine follows a defined journey. Learn the five key stages of modern drug discovery. 👉 youtu.be/SLS2C6uPxSA #DrugDevelopment #PharmaceuticalIndustry #SkyHealthAcademy

HealthSkyAcad's tweet image. From target identification to clinical trials — every breakthrough medicine follows a defined journey.
Learn the five key stages of modern drug discovery.
👉 youtu.be/SLS2C6uPxSA

#DrugDevelopment #PharmaceuticalIndustry #SkyHealthAcademy

Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: f.mtr.cool/nbhtkiwlsp

CPathInstitute's tweet image. Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: f.mtr.cool/nbhtkiwlsp

Abzena and Mabqi form strategic partnership to provide drug development solution Read more here: bit.ly/47YHEbM Subscribe to our weekly newsletter for the latest news delivered to your inbox: scientistlive.com/content/newsbr… #science #pharma #drugdevelopment

Scientist_Live1's tweet image. Abzena and Mabqi form strategic partnership to provide drug development solution

Read more here: bit.ly/47YHEbM 

Subscribe to our weekly newsletter for the latest news delivered to your inbox: scientistlive.com/content/newsbr… 

#science #pharma #drugdevelopment

Heading to AAPS 2025 PharmSci 360? Stop by booth #3458 for live Phoenix & Simcyp demos, expert insights, and the latest in model-informed drug development. Schedule a meeting: ow.ly/yhAp50XmzUR #PharmSci360 #DrugDevelopment

Certara's tweet image. Heading to AAPS 2025 PharmSci 360? Stop by booth #3458 for live Phoenix & Simcyp demos, expert insights, and the latest in model-informed drug development.

Schedule a meeting: ow.ly/yhAp50XmzUR

#PharmSci360 #DrugDevelopment

$CGEM - Cullinan Therapeutics Inc. Common Stock - 10Q - Updated Risk Factors CGEM warns that challenges enrolling patients have delayed trials and could further stall or block clinical progress and regulatory approvals. #Biotechnology #DrugDevelopment #PatientEnrollment

d__risk's tweet image. $CGEM - Cullinan Therapeutics Inc. Common Stock - 10Q - Updated Risk Factors

CGEM warns that challenges enrolling patients have delayed trials and could further stall or block clinical progress and regulatory approvals. #Biotechnology #DrugDevelopment #PatientEnrollment…

Building a $1.2B factory for a drug that isn't even approved yet? Eli Lilly is betting big on its oral weight-loss pill, expanding its Puerto Rico plant before the FDA gives the green light. A bold move in a very crowded race. #Pharma #Biotech #DrugDevelopment


How can #AI transform #RegenerativeMedicine? Join us 11/18 for a hybrid workshop exploring how AI can enhance the translation of regenerative medicine therapies through its role in #DrugDevelopment, #ClinicalTrials, & biomanufacturing: ow.ly/rMI350X9X8E #RegenMedForum

NASEM_Health's tweet image. How can #AI transform #RegenerativeMedicine? Join us 11/18 for a hybrid workshop exploring how AI can enhance the translation of regenerative medicine therapies through its role in #DrugDevelopment, #ClinicalTrials, & biomanufacturing: ow.ly/rMI350X9X8E  #RegenMedForum

Unlock new possibilities in biomedical research! Discover how Optimers are transforming science in the FREE eBook from @AptamerGroup: hubs.li/Q03R1S0-0 #Antibodies #Optimers #DrugDevelopment

GENbio's tweet image. Unlock new possibilities in biomedical research! Discover how Optimers are transforming science in the FREE eBook from @AptamerGroup: hubs.li/Q03R1S0-0 #Antibodies #Optimers #DrugDevelopment

#ESMO2025 Berlin is SOON here 🇩🇪 🚀 My #Top10 for #drugdevelopment @myESMO Interesting new drugs coming out 🙌🏽 🧫 CAR-T 💉 ADC 🦠 Vaccines 🧪 New#ICIs 🎯 #therapies @ASCO @_SEOM @VHIO @MDAndersonNews @OncBrothers 🌍 Follow: #OncoAlertAF @OncoAlert What do you think? 💭👇🏽

DrMirallas's tweet image. #ESMO2025 Berlin is SOON here 🇩🇪

🚀 My #Top10 for #drugdevelopment @myESMO

Interesting new drugs coming out 🙌🏽
🧫 CAR-T
💉 ADC
🦠 Vaccines
🧪 New#ICIs
🎯 #therapies

@ASCO @_SEOM @VHIO @MDAndersonNews @OncBrothers

🌍 Follow:
#OncoAlertAF @OncoAlert

What do you think? 💭👇🏽

Is CRBP stock just practicing its yoga poses with all these ups and downs? Source: finquota.com/CRBP/ #StockMarket #DrugDevelopment #ClinicalTrials #NYSE #stock #stocks

FinQuota's tweet image. Is CRBP stock just practicing its yoga poses with all these ups and downs?

Source: finquota.com/CRBP/

#StockMarket #DrugDevelopment #ClinicalTrials #NYSE #stock #stocks

Every stage of drug development benefits from the right expertise. Explore how choosing between a CDMO, CMO, or CRO can define your project’s progress in our new blog. Read the full article here: hubs.la/Q03Q9lx-0 #NeulandLabs #CDMO #DrugDevelopment #Outsourcing

NeulandLabs's tweet image. Every stage of drug development benefits from the right expertise. Explore how choosing between a CDMO, CMO, or CRO can define your project’s progress in our new blog.
Read the full article here: hubs.la/Q03Q9lx-0 

#NeulandLabs #CDMO #DrugDevelopment #Outsourcing

Pretty intense May. #Vaccinology 💉 #DrugDevelopment 💊 #MVDD #UniSi

AJNadabo's tweet image. Pretty intense May. 
#Vaccinology 💉 
#DrugDevelopment 💊 
#MVDD 
#UniSi
AJNadabo's tweet image. Pretty intense May. 
#Vaccinology 💉 
#DrugDevelopment 💊 
#MVDD 
#UniSi
AJNadabo's tweet image. Pretty intense May. 
#Vaccinology 💉 
#DrugDevelopment 💊 
#MVDD 
#UniSi
AJNadabo's tweet image. Pretty intense May. 
#Vaccinology 💉 
#DrugDevelopment 💊 
#MVDD 
#UniSi

may dump ?



For over 10 years, we have made #DrugDiscovery & development steps faster & more predictable. Using what we’ve learned, we create educational resources to share this information with the #TranslationalScience community. To improve understanding of the complex #DrugDevelopment &…

ncats_nih_gov's tweet image. For over 10 years, we have made #DrugDiscovery & development steps faster & more predictable. Using what we’ve learned, we create educational resources to share this information with the #TranslationalScience community.

To improve understanding of the complex #DrugDevelopment &…
ncats_nih_gov's tweet image. For over 10 years, we have made #DrugDiscovery & development steps faster & more predictable. Using what we’ve learned, we create educational resources to share this information with the #TranslationalScience community.

To improve understanding of the complex #DrugDevelopment &…

Unlock the potential of HPAPIs in oncology. With safety-first manufacturing, peptide API expertise & seamless scale-up, Piramal Pharma Solutions advances your oncology pipeline with confidence. Read our blog: piramalpharmasolutions.com/resources/blog… #HPAPI #Oncology #DrugDevelopment #CDMO

PiramalPharma's tweet image. Unlock the potential of HPAPIs in oncology. With safety-first manufacturing, peptide API expertise & seamless scale-up, Piramal Pharma Solutions advances your oncology pipeline with confidence. Read our blog: piramalpharmasolutions.com/resources/blog… #HPAPI #Oncology #DrugDevelopment #CDMO

Totally agree @curijoey - taking a post-#ESMO25 recovery pause in your beautiful home country 🇮🇹 🍷🫒⛪️ at the moment… before return to #drugdevelopment rat race! 🇦🇺

JiaJennyLiu's tweet image. Totally agree @curijoey - taking a post-#ESMO25 recovery pause in your beautiful home country 🇮🇹 🍷🫒⛪️ at the moment… before return to #drugdevelopment rat race! 🇦🇺
JiaJennyLiu's tweet image. Totally agree @curijoey - taking a post-#ESMO25 recovery pause in your beautiful home country 🇮🇹 🍷🫒⛪️ at the moment… before return to #drugdevelopment rat race! 🇦🇺

Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿

curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿


GI toxicity is a major side effect of cancer therapies. Our 3D Colon Organoid Model brings human relevance + high-throughput screening to better predict drug-induced GI toxicity. Explore our poster 👉 shorturl.at/8APaR #Toxicology #Organoids #DrugDevelopment #Innovation

MIMETAS_3D's tweet image. GI toxicity is a major side effect of cancer therapies. Our 3D Colon Organoid Model brings human relevance + high-throughput screening to better predict drug-induced GI toxicity. Explore our poster 👉 shorturl.at/8APaR #Toxicology #Organoids #DrugDevelopment #Innovation

⏳ Last chance! 2025 Innovation Awards nominations close Nov 7. Free to enter. Big visibility. ✅ Pharma & biopharma tech launched Nov 2024–Dec 2025 👉 Submit now: ow.ly/HLbX50X1qFA #Pharma #Biotech #DrugDevelopment #CGT #Innovation

medicine_maker's tweet image. ⏳ Last chance!
2025 Innovation Awards nominations close Nov 7.

Free to enter. Big visibility.
✅ Pharma & biopharma tech launched Nov 2024–Dec 2025
👉 Submit now: ow.ly/HLbX50X1qFA

#Pharma #Biotech #DrugDevelopment #CGT #Innovation

Join us in Frankfurt as our experts share how cutting-edge science, automation, and advanced platforms are transforming development and supply! 👉 Schedule a 1:1 meeting with our team and explore what’s next for your mission: ow.ly/6SY050Xgji2 #CPHI2025 #DrugDevelopment

Catalent_'s tweet image. Join us in Frankfurt as our experts share how cutting-edge science, automation, and advanced platforms are transforming development and supply!

👉 Schedule a 1:1 meeting with our team and explore what’s next for your mission: ow.ly/6SY050Xgji2

 #CPHI2025 #DrugDevelopment

BioNxt has launched a 15-day dosing optimisation study for its sublingual multiple sclerosis (MS) drug, marking the final step before human bioequivalence testing planned for early 2026. 🔗 Full story: buff.ly/gPjwCF7 #MultipleSclerosis #NeuroResearch #DrugDevelopment

editorNRTimes's tweet image. BioNxt has launched a 15-day dosing optimisation study for its sublingual multiple sclerosis (MS) drug, marking the final step before human bioequivalence testing planned for early 2026. 

🔗 Full story: buff.ly/gPjwCF7 

#MultipleSclerosis #NeuroResearch #DrugDevelopment…

Thank you to everyone who attended our recent seminar in Copenhagen! We had an incredible time connecting with innovators across the life sciences community to explore strategies for de-risking emerging new chemical modalities. #MVA #DrugDevelopment #PharmaInnovation

Catalent_'s tweet image. Thank you to everyone who attended our recent seminar in Copenhagen!

We had an incredible time connecting with innovators across the life sciences community to explore strategies for de-risking emerging new chemical modalities. 

#MVA #DrugDevelopment #PharmaInnovation
Catalent_'s tweet image. Thank you to everyone who attended our recent seminar in Copenhagen!

We had an incredible time connecting with innovators across the life sciences community to explore strategies for de-risking emerging new chemical modalities. 

#MVA #DrugDevelopment #PharmaInnovation
Catalent_'s tweet image. Thank you to everyone who attended our recent seminar in Copenhagen!

We had an incredible time connecting with innovators across the life sciences community to explore strategies for de-risking emerging new chemical modalities. 

#MVA #DrugDevelopment #PharmaInnovation
Catalent_'s tweet image. Thank you to everyone who attended our recent seminar in Copenhagen!

We had an incredible time connecting with innovators across the life sciences community to explore strategies for de-risking emerging new chemical modalities. 

#MVA #DrugDevelopment #PharmaInnovation

Final call: Dr. George Church will be speaking about how DNA sequencing is becoming more accessible, transforming #drugdevelopment for #precisionmedicine. Join our next Genomics for Health webinar tomorrow 👉 event.on24.com/wcc/r/5025154/…

QIAGENBiox's tweet image. Final call: Dr. George Church will be speaking about how DNA sequencing is becoming more accessible, transforming #drugdevelopment for #precisionmedicine. Join our next Genomics for Health webinar tomorrow 👉 event.on24.com/wcc/r/5025154/…

Can human mini-Hearts advance cardiovascular drug development? ddw-online.com/how-human-mini… Follow DDW; Business insights for the global scientific community #DrugDevelopment

DDWJournal's tweet image. Can human mini-Hearts advance cardiovascular drug development?

ddw-online.com/how-human-mini…

Follow DDW; Business insights for the global scientific community
#DrugDevelopment

‼️ Interested in use of registries for #oncology #DrugDevelopment & #regulatory decision-making? Or in pediatric #braintumor DMG/#DIPG? This is for you! Day 2 of free virtual public workshop: Th 8/28 10a-1p EDT. #ayacsm #btsm #raretumors #MedTwitter Link to register ⬇️ in 🧵

tmprowell's tweet image. ‼️ Interested in use of registries for #oncology #DrugDevelopment & #regulatory decision-making? Or in pediatric #braintumor DMG/#DIPG? This is for you! 

Day 2 of free virtual public workshop: Th 8/28 10a-1p EDT.

#ayacsm #btsm #raretumors
#MedTwitter 

Link to register ⬇️ in 🧵

Quality drug candidates in under 2 years November 10, 8 am PST / 11 am EST / 4 pm GMT / 5 pm CET Register here now! attendee.gotowebinar.com/register/84853… Follow DDW; Business insights for the global scientific community Supported by @Evotec #DrugDevelopment

DDWJournal's tweet image. Quality drug candidates in under 2 years

November 10, 8 am PST / 11 am EST / 4 pm GMT / 5 pm CET
Register here now!
attendee.gotowebinar.com/register/84853…

Follow DDW; Business insights for the global scientific community
Supported by @Evotec 
#DrugDevelopment

Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma

omalirp's tweet image. Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma
omalirp's tweet image. Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma

DNA sequencing? In this economy? Yes, precisely because of the current economy. 💸 Learn how the increasing accessibility of #DNAsequencing is changing the #drugdevelopment game and slashing drug prices. Join us on Sept. 9 👉 event.on24.com/wcc/r/5025154/…

QIAGENBiox's tweet image. DNA sequencing? In this economy?
Yes, precisely because of the current economy. 💸 Learn how the increasing accessibility of #DNAsequencing is changing the #drugdevelopment game and slashing drug prices. Join us on Sept. 9 👉 event.on24.com/wcc/r/5025154/…

Loading...

Something went wrong.


Something went wrong.


United States Trends